Literature DB >> 9120280

Peptide binding to the class Ib molecule, Qa-1b.

Z Kurepa1, J Forman.   

Abstract

We have analyzed the interaction of a nonameric peptide (Qdm) derived from the leader sequence of a MHC D region molecule with the class Ib molecule, Qa-1b. Using a direct binding assay with radiolabeled peptide on intact cells, we show specific binding of iodinated Qdm peptide to Qa-1b expressing cells. Specificity was confirmed by experiments in which the binding of iodinated peptide was blocked by unlabeled Qdm and not by control peptides. This allowed us to determine the on- and off-rate of peptide binding to Qa-1b, its binding affinity, and number of available peptide-binding sites per cell. Optimal binding occurs at 4 degrees C, and most of the binding to Qa-1b occurs within the first 10 min and peaks after 3 h. The dissociation of the peptide from cells has a t1/2 of approximately 10 h. The Kd is calculated between 0.2 and 1.1 x 10(-10) M, which is in the range or slightly higher than the Kd we measured for pMCMV to Ld (0.9 x 10(-10) M). The relatively high affinity of binding of the Qdm peptide and low dissociation rate could partially explain why a large portion of Qa-1b molecules are occupied with this single peptide species. We also changed each peptide residue to Ala or Gly to determine its effect on binding. Substitution of Leu at position 9 to Ala strongly reduced peptide binding, while changes at positions 2 (Met-->Ala) and 5 (Arg-->Ala) had a lesser effect. Binding to Qa-1b was completely abrogated with simultaneous Ala mutations at positions 2 and 9.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9120280

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Constitutive and regulated expression of the class IB molecule Qa-1 in pancreatic beta cells.

Authors:  T Chun; C J Aldrich; M E Baldeón; L V Kawczynski; M J Soloski; H R Gaskins
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

2.  Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes.

Authors:  J R Kraft; R E Vance; J Pohl; A M Martin; D H Raulet; P E Jensen
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

3.  Transporters associated with antigen processing (TAP)-independent presentation of soluble insulin to alpha/beta T cells by the class Ib gene product, Qa-1(b).

Authors:  S M Tompkins; J R Kraft; C T Dao; M J Soloski; P E Jensen
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

4.  Qa-1b binds conserved class I leader peptides derived from several mammalian species.

Authors:  Z Kurepa; C A Hasemann; J Forman
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

5.  Targeting Non-classical Myelin Epitopes to Treat Experimental Autoimmune Encephalomyelitis.

Authors:  Xiaohua Wang; Jintao Zhang; David J Baylink; Chih-Huang Li; Douglas M Watts; Yi Xu; Xuezhong Qin; Michael H Walter; Xiaolei Tang
Journal:  Sci Rep       Date:  2016-10-31       Impact factor: 4.379

6.  Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b).

Authors:  R E Vance; J R Kraft; J D Altman; P E Jensen; D H Raulet
Journal:  J Exp Med       Date:  1998-11-16       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.